{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:40:18Z","timestamp":1778629218074,"version":"3.51.4"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/bf02988521","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T06:46:20Z","timestamp":1226731580000},"page":"261-279","source":"Crossref","is-referenced-by-count":141,"title":["Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) \u2014Usefulness and limitations in \u201cclinical reality\u201d\u2014"],"prefix":"10.1007","volume":"17","author":[{"given":"Tatsuya","family":"Higashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Saga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichiro","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02988521_CR1","unstructured":"Statistical Information Bureau, Ministry of Health, Welfare, and Labor. Statistics of Japanese Population: 1997. Tokyo, Japan, 1997."},{"key":"BF02988521_CR2","unstructured":"American Cancer Society. Cancer facts and figures 1991. Atlanta, 1991."},{"key":"BF02988521_CR3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/PL00002512","volume":"67","author":"T Bottger","year":"1996","unstructured":"Bottger T, Hassdenteufel A, Boddin J, Kuchle R, Junginger T, Prellwitz W. Value of the CA 19\u20139 tumor markers in differential diagnosis of space occupying lesions of the head of the pancreas.Chirurg 1996; 67: 1007\u20131011.","journal-title":"Chirurg"},{"key":"BF02988521_CR4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00006676-199209000-00001","volume":"7","author":"HT Lynch","year":"1992","unstructured":"Lynch HT, Fusaro L, Lynch JF. Familial pancreatic cancer: a family study.Pancreas 1992; 7: 511\u2013515.","journal-title":"Pancreas"},{"key":"BF02988521_CR5","first-page":"678","volume":"24","author":"M Zimny","year":"1997","unstructured":"Zimny M, Bares R, Fab J, Adam G, Cremerius U, Dohmen B, et al. Fluorine-18 fluorodeoxyglucose positron tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.Eur J Nucl Med 1997; 24: 678\u2013682.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR6","first-page":"115","volume":"16","author":"M Matsuno","year":"2001","unstructured":"Matsuno M. Annual report of national surveillance of pancreatic cancers in Japan.Jpn Panc Soc 2001; 16: 115\u2013147. (Japanese)","journal-title":"Jpn Panc Soc"},{"key":"BF02988521_CR7","first-page":"1927","volume":"31","author":"K Kubota","year":"1990","unstructured":"Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study.J Nucl Med 1990; 31: 1927\u20131932.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1148\/radiology.179.3.2027989","volume":"179","author":"RL Wahl","year":"1991","unstructured":"Wahl RL, Cody RL, Hutchins GD. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analog 2-[18F]-fluoro-2-deoxy-d-glucose.Radiology 1991; 179: 765\u2013770.","journal-title":"Radiology"},{"key":"BF02988521_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiology.170.2.2783494","volume":"170","author":"LG Strauss","year":"1989","unstructured":"Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, et al. Recurrence of colorectal tumors: PET evaluation.Radiology 1989; 170: 329\u2013332.","journal-title":"Radiology"},{"key":"BF02988521_CR10","first-page":"1133","volume":"23","author":"Y Yonekura","year":"1982","unstructured":"Yonekura Y, Benua RS, Brill AB, Som P, Yeh SD, Kemeny NE, et al. Increased accumulation of 2-deoxy-2-[18F]Fluoro-d-glucose in liver metastases from colon carcinoma.J Nucl Med 1982; 23: 1133\u20131137.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR11","first-page":"A434","volume":"9","author":"I Zanzi","year":"1990","unstructured":"Zanzi I, Robeson W, Vinciguerra V. Positron emission tomography (PET) imaging in patients with carcinoma of the pancreas [abstract]. Proc. A.S.C.O. 9: A434, 1990.","journal-title":"Proc. A.S.C.O."},{"key":"BF02988521_CR12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(92)93183-N","volume":"340","author":"P Klever","year":"1992","unstructured":"Klever P, Bares R, Fass J, Bull U, Schumpelick V. PET with fluorine-18 deoxyglucose for pancreatic disease.Lancet 1992; 340: 1158.","journal-title":"Lancet"},{"key":"BF02988521_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1148\/radiology.192.1.8208970","volume":"192","author":"R Bares","year":"1994","unstructured":"Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PETin vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.Radiology 1994; 192: 79\u201386.","journal-title":"Radiology"},{"key":"BF02988521_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiology.195.2.7724751","volume":"195","author":"T Inokuma","year":"1995","unstructured":"Inokuma T, Tamaki N, Torizuka T, Magata Y, Fujii M, Yonekura Y, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.Radiology 1995; 195: 345\u2013352.","journal-title":"Radiology"},{"key":"BF02988521_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002590050226","volume":"25","author":"PD Shreve","year":"1998","unstructured":"Shreve PD. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.Eur J Nucl Med 1998; 25: 259\u2013264.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/BF03215860","volume":"25","author":"RK Kasperk","year":"2001","unstructured":"Kasperk RK, Riesener KP, Wilms K, Schumpelick V. Limited value of positron emission tomography in treatment of pancreatic cancer: surgeon's view.World J Surg 2001; 25: 1134\u20131139.","journal-title":"World J Surg"},{"key":"BF02988521_CR17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s002680010182","volume":"24","author":"A Sendler","year":"2000","unstructured":"Sendler A, Avril N, Helmberger H, Stollfus J, Weber W, Bengel F, et al. Preoperative evaluation of pancreatic masses with positron emission tomography using18F-fluorodeoxyglucose: Diagnostic limitations.World J Surg 2000; 24: 1121\u20131129.","journal-title":"World J Surg"},{"key":"BF02988521_CR18","first-page":"229","volume":"36","author":"T Inokuma","year":"1995","unstructured":"Inokuma T, Tamaki N, Torizuka T, Fujita T, Magata Y, Yonekura Y, et al. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.J Nucl Med 1995; 36: 229\u2013235.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR19","first-page":"1337","volume":"38","author":"T Higashi","year":"1997","unstructured":"Higashi T, Tamaki N, Honda T, Torizuka T., Kimura T, Inokuma T, et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.J Nucl Med 1997; 38: 1337\u20131344.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR20","first-page":"1727","volume":"39","author":"T Higashi","year":"1998","unstructured":"Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, et al. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.J Nucl Med 1998; 39: 1727\u20131735.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR21","first-page":"1424","volume":"40","author":"T Higashi","year":"1999","unstructured":"Higashi T, Sakahara H, Torizuka T, Nakamoto Y, Kanamori S, Hiraoka M, et al. Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.J Nucl Med 1999; 40: 1424\u20131433.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9260(99)91160-1","volume":"54","author":"Y Nakamoto","year":"1999","unstructured":"Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Imamura M, et al. Contribution of PET in the detection of liver metastases from pancreatic tumours.Clinical Radiology 1999; 54: 248\u2013252.","journal-title":"Clinical Radiology"},{"key":"BF02988521_CR23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00003072-199910000-00009","volume":"24","author":"Y Nakamoto","year":"1999","unstructured":"Nakamoto Y, Sakahara H, Higashi T, Saga T, Sato N, Okazaki K, et al. Autoimmune pancreatitis with F-18 fluoro-2-deoxy-d-glucose PET findings.Clin Nucl Med 1999; 24: 778\u2013780.","journal-title":"Clin Nucl Med"},{"key":"BF02988521_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00003072-200002000-00007","volume":"25","author":"Y Nakamoto","year":"2000","unstructured":"Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Itoh K, Imamura M, et al. Evaluation of pancreatic islet cell tumors by fluorine-18 fluurdeoxyglucose positron emission tomography: comparison with other modalities.Clin Nucl Med 2000; 25: 115\u2013119.","journal-title":"Clin Nucl Med"},{"key":"BF02988521_CR25","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V","volume":"89","author":"Y Nakamoto","year":"2000","unstructured":"Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed FDG-PET Scan for Differentiation Between Malignant and Benign Lesions in the Pancreas.Cancer 2000; 89: 2547\u20132554.","journal-title":"Cancer"},{"key":"BF02988521_CR26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s002590000370","volume":"27","author":"Y Nakamoto","year":"2000","unstructured":"Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, et al. FDG-PET of autoimmune-related pancreatitis: preliminary results.Eur J Nucl Med 2000; 27: 1835\u20131838.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF02988499","volume":"15","author":"K Kubota","year":"2001","unstructured":"Kubota K. From tumor biology to clinicals PET: A review of positron emission tomography (PET) in oncology.Ann Nucl Med 2001; 15: 471\u2013486.","journal-title":"Ann Nucl Med"},{"key":"BF02988521_CR28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1146\/annurev.ph.54.030192.004403","volume":"54","author":"JE Pessin","year":"1992","unstructured":"Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation.Annu Rev Physiol 1992; 54: 911\u2013930.","journal-title":"Annu Rev Physiol"},{"key":"BF02988521_CR29","first-page":"173","volume":"43","author":"T Higashi","year":"2002","unstructured":"Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede MH, Wada M, et al. Relationship between retention index in dual-phase18F-FDG-PET, hexokinase-II and glucose transporter-1 expression in pancreatic cancers.J Nucl Med 2002; 43: 173\u2013180.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR30","first-page":"1344","volume":"38","author":"S Reske","year":"1997","unstructured":"Reske S, Grillenberger K, Glatting G Port M, Hildebrandt M, Gansauge F, et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.J Nucl Med 1997; 38: 1344\u20131348.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR31","first-page":"3972","volume":"52","author":"T Nishioka","year":"1992","unstructured":"Nishioka T, Oda Y, Seino Y, Yamamoto T, Inagaki N, Yano H, et al. Distribution of glucose transporters in human brain tumors.Cancer Res 1992; 52: 3972\u20133979.","journal-title":"Cancer Res"},{"key":"BF02988521_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-291X(90)91263-R","volume":"170","author":"T Yamamoto","year":"1990","unstructured":"Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, et al. Over-expression of facilitative glucose transporter genes in human cancer.Biochem Biophys Res Commun 1990; 170: 223\u2013230.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02988521_CR33","first-page":"285","volume":"56","author":"TA Smith","year":"1999","unstructured":"Smith TA. Facilitative glucose transporter expression in human cancer tissue.Br J Biomed Sci 1999; 56: 285\u2013292.","journal-title":"Br J Biomed Sci"},{"key":"BF02988521_CR34","first-page":"437","volume":"11","author":"T Ito","year":"1998","unstructured":"Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differetiation grade, and tumor grade.Mod Pathol 1998; 11: 437\u2013443.","journal-title":"Mod Pathol"},{"key":"BF02988521_CR35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X","volume":"92","author":"T Kawamura","year":"2001","unstructured":"Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.Cancer 2001; 92: 634\u2013641.","journal-title":"Cancer"},{"key":"BF02988521_CR36","first-page":"2895","volume":"15","author":"M Younes","year":"1995","unstructured":"Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers.Anticancer Res 1995; 15: 2895\u20132898.","journal-title":"Anticancer Res"},{"key":"BF02988521_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BFb0049776","volume":"126","author":"JE Wilson","year":"1995","unstructured":"Wilson JE. Hexokinase.Rev Physiol Biochem Pharmacol 1995; 126: 65\u2013198.","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"BF02988521_CR38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1022442629543","volume":"29","author":"SG Golshani-Hebroni","year":"1997","unstructured":"Golshani-Hebroni SG, Bessmann SP. Hexokinase binding to mitochondria: a basis for proliferative energy metabolism.J Bioenergetics Biomembranes 1997; 29: 331\u2013338.","journal-title":"J Bioenergetics Biomembranes"},{"key":"BF02988521_CR39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/bj2650503","volume":"265","author":"M Board","year":"1990","unstructured":"Board M, Humm S, Newsholme EA. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid acyte in normal, neoplastic and suppressed cells.Biochem J 1990; 265: 503\u2013509.","journal-title":"Biochem J"},{"key":"BF02988521_CR40","first-page":"2240","volume":"30","author":"WE Knox","year":"1970","unstructured":"Knox WE, Jamdar SC, Davis PA. Hexokinase, differentiation and growth rates of transplanted rat tumors.Cancer Res 1970; 30: 2240\u20132244.","journal-title":"Cancer Res"},{"key":"BF02988521_CR41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006231-199802000-00002","volume":"19","author":"TA Smith","year":"1998","unstructured":"Smith TA. FDG uptake, tumour characteristics and response to therapy: a review.Nucl Med Commun 1998; 19: 97\u2013105.","journal-title":"Nucl Med Commun"},{"key":"BF02988521_CR42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0969-8051(96)00037-6","volume":"23","author":"CA Nelson","year":"1996","unstructured":"Nelson CA, Wang JQ, Leav I, Crane PD. The interaction among glucose transporter, hexokinase, and glucose-6-phosphate with respect to3H-2-deoxyglucose retention in murine tumor models.Nucl Med Biol 1996; 23: 533\u2013541.","journal-title":"Nucl Med Biol"},{"key":"BF02988521_CR43","first-page":"1811","volume":"36","author":"T Torizuka","year":"1995","unstructured":"Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, et al.In vivo assessments of glucose metabolism in hepatocellular carcinoma with FDG PET.J Nucl Med 1995; 36: 1811\u20131817.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.J Neurochemistry 1977; 28: 897\u2013916.","journal-title":"J Neurochemistry"},{"key":"BF02988521_CR45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s002590050355","volume":"26","author":"MA Lodge","year":"1999","unstructured":"Lodge MA, Lucas JD, Marsden PK, Cronin BF, O'Doherty MJ, Smith MA. A PET study of18FDG uptake in soft tissue masses.Eur J Nucl Med 1999; 26: 22\u201330.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s002590050381","volume":"26","author":"AR Boerner","year":"1999","unstructured":"Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, et al. Optimal scan time for fluorine-18 fluorode-oxyglucose positron emission tomography in breast cancer.Eur J Nucl Med 1999; 26: 226\u2013230.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s002590100537","volume":"28","author":"K Kubota","year":"2001","unstructured":"Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed imaging of whole-body FDG-PET for tumor detection.Eur J Nucl Med 2001; 28: 696\u2013703.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR48","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s002590050593","volume":"26","author":"R Hustinx","year":"1999","unstructured":"Hustinx R, Smith RJ, Benard F, Rosenthal DI, Machtay M, Farber LA, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.Eur J Nucl Med 1999; 26: 1345\u20131348.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR49","first-page":"871","volume":"43","author":"A Matthies","year":"2002","unstructured":"Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point18F-FDG PET for the evaluation of pulmonary nodules.J Nucl Med 2002; 43: 871\u2013875.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02996297","volume":"16","author":"K Koyama","year":"2002","unstructured":"Koyama K, Okamura T, Kawabe J, Ozawa N, Higashiyama S, Ochi H, et al. The usefulness of18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor.Ann Nucl Med 2002; 16: 169\u2013176.","journal-title":"Ann Nucl Med"},{"key":"BF02988521_CR51","first-page":"6","volume":"34","author":"AJ Fischman","year":"1993","unstructured":"Fischman AJ, Alpert NM. FDG-PET in oncology: There's more to it than looking at pictures.J Nucl Med 1993; 34: 6\u201311.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR52","first-page":"1308","volume":"35","author":"LM Hamberg","year":"1994","unstructured":"Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification.J Nucl Med 1994; 35: 1308\u20131312.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR53","first-page":"1836","volume":"36","author":"JW Keyes","year":"1995","unstructured":"Keyes JW. Standard uptake or silly useless value?J Nucl Med 1995; 36: 1836\u20131839.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF02988345","volume":"15","author":"K Oda","year":"2001","unstructured":"Oda K, Toyama H, Umehara, K, Ikoma Y, Kimura Y, Senda M. Comparison of parametric FBP and OS-EM reconstruction algorithm images for PET dynamic study.Ann Nucl Med 2001; 15: 417\u2013423.","journal-title":"Ann Nucl Med"},{"key":"BF02988521_CR55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00259-001-0697-x","volume":"29","author":"EU Nitzche","year":"2002","unstructured":"Nitzche EU, Hoegerle S, Mix M, Brink I, Otte A, Moser E, Imdahl A. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?Eur J Nucl Med Mol Imaging 2002; 29: 237\u2013242.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF02988521_CR56","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/BF01367602","volume":"23","author":"LG Strauss","year":"1996","unstructured":"Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.Eur J Nucl Med 1996; 23: 1409\u20131415.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF00997245","volume":"22","author":"T Kato","year":"1995","unstructured":"Kato T, Fukatsu H, Ito K, Tadokoro M, Ota T, Ikeda M, et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: unsolved problem.Eur J Nucl Med 1995; 22: 32\u201339.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR58","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s002590000277","volume":"27","author":"KD Stumpe","year":"2000","unstructured":"Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET.Eur J Nucl Med 2000; 27: 822\u2013832.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR59","first-page":"419","volume":"34","author":"R Kubota","year":"1993","unstructured":"Kubota R, Kubota K, Yamada S. FDG accumulation in tumor tissue (Editorial).J Nucl Med 1993; 34: 419\u2013421.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR60","first-page":"1972","volume":"33","author":"R Kubota","year":"1992","unstructured":"Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucosein vivo: high accumulation in macrophages and granuation tissues studied by microautoradiography.J Nucl Med 1992; 33: 1972\u20131980.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR61","first-page":"104","volume":"35","author":"R Kubota","year":"1994","unstructured":"Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granuation tissues and cancer cells by the dynamics of fluorine-18-fluoro-deoxyglucose uptake.J Nucl Med 1994; 35: 104\u2013112.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR62","first-page":"414","volume":"34","author":"K Higashi","year":"1993","unstructured":"Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells?In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.J Nucl Med 1993; 34: 414\u2013419.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.174.4.1741005","volume":"174","author":"KL Berger","year":"2000","unstructured":"Berger KL, Nicholson SA, Dehdashtl F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.AJR Am J Roentgenol 2000; 174: 1005\u20131008.","journal-title":"AJR Am J Roentgenol"},{"key":"BF02988521_CR64","first-page":"108","volume":"65","author":"B Lippitz","year":"1996","unstructured":"Lippitz B, Cremerlus U, Mayfrank L, Bertalanffy H, Raoofl R, Wels J, et al. PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate.Acta Neurochir Suppl (Wien) 1996; 65: 108\u2013111.","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"BF02988521_CR65","first-page":"1279","volume":"6","author":"AL Folpe","year":"2000","unstructured":"Folpe AL, Lyles RH, Sprouse JT, Conrad EU, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognosis variables in bone and soft tissue sarcoma.Clin Cancer Res 2000; 6: 1279\u20131287.","journal-title":"Clin Cancer Res"},{"key":"BF02988521_CR66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00259-002-0978-z","volume":"30","author":"Y Kitagawa","year":"2003","unstructured":"Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.Eur J Nucl Med Mol Imaging 2003; 30; 63\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF02988521_CR67","first-page":"1030","volume":"39","author":"CG Diederichs","year":"1998","unstructured":"Diederichs CG, Staib L, Glatting G Beger HG, Reske SN. FDG-PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.J Nucl Med 1998; 39: 1030\u20131033.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR68","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/gut.36.5.771","volume":"36","author":"H Friess","year":"1995","unstructured":"Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-d-glucose positron emission tomography.Gut 1995; 36: 771\u2013777.","journal-title":"Gut"},{"key":"BF02988521_CR69","first-page":"382","volume":"38","author":"T Torizuka","year":"1997","unstructured":"Torizuka T, Clavo AC, Wahl RL. Effect of hyperglycemia onin vitro tumor uptake of tritiated FDG, thymidine,l-methionine andl-leucine.J Nucl Med 1997; 38: 382\u2013386.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s001250050026","volume":"43","author":"T Hahn","year":"2000","unstructured":"Hahn T, Hahn D, Blaschitz A, Korgun ET, Desoye G, Dohr G. Hyperglycaemia-induced subcellular redistribution of GLUT1 glucose transporters in cultured human term placental trophoblast cells.Diabetologia 2000; 43: 173\u2013180.","journal-title":"Diabetologia"},{"key":"BF02988521_CR71","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1006\/jmcc.1999.0965","volume":"31","author":"S Egert","year":"1999","unstructured":"Egert S, Nguyen N, Schwaiger M. Myocardial glucose transporter GLUT1: translocation induced by insulin and ischemia.J Mol Cell Cardiol 1999; 31: 1337\u20131344.","journal-title":"J Mol Cell Cardiol"},{"key":"BF02988521_CR72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fasebj.8.1.8299889","volume":"8","author":"A Klip","year":"1994","unstructured":"Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: a review of studiesin vivo and in cell cultures.FASEB J 1994; 8: 43\u201353.","journal-title":"FASEB J"},{"key":"BF02988521_CR73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<353::AID-IJC16>3.0.CO;2-7","volume":"78","author":"T Hahn","year":"1998","unstructured":"Hahn T, Barth S, Hofmann W, Reich O, Lang I, Desoye G. Hyperglycemia regulates the glucose-transport system of clonal choriocarcinoma cellsin vitro. A potential molecular mechanism contributing to the adjunct effect of glucose in tumor therapy.Int J Cancer 1998; 78: 353\u2013360.","journal-title":"Int J Cancer"},{"key":"BF02988521_CR74","first-page":"1784","volume":"40","author":"D Delbeke","year":"1999","unstructured":"Delbeke D, Rose DM, Chapman WC, et al. Optimal interpretation of FDG-PET in the diagnosis, staging and management of pancreatic carcinoma.J Nucl Med 1999; 40: 1784\u20131791.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02987835","volume":"15","author":"K Koyama","year":"2001","unstructured":"Koyama K, Okamura T, Kawabe J, Nakata B, Chung KH, Ochi H, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions.Ann Nucl Med 2001; 15: 217\u2013224.","journal-title":"Ann Nucl Med"},{"key":"BF02988521_CR76","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1148\/radiology.208.2.9680582","volume":"208","author":"T Torizuka","year":"1998","unstructured":"Torizuka T, Fisher SJ, Brown RS, Wahl RL. Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats.Radiology 1998; 208: 499\u2013504.","journal-title":"Radiology"},{"key":"BF02988521_CR77","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1365-2168.1999.01016.x","volume":"86","author":"A Imdahl","year":"1999","unstructured":"Imdahl A, Nitzche E, Krautmann F, Hogerle S, Boos S, Einert A, et al. Evaluation of positom emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.Br J Surg 1999; 86: 194\u2013199.","journal-title":"Br J Surg"},{"key":"BF02988521_CR78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiology.195.2.7724750","volume":"195","author":"JC Stollfuss","year":"1995","unstructured":"Stollfuss JC, Glatting G, Fries H, Kocher F, Berger HG, Reske SN. 2-(fluorine-18)-fluoro-2-deoxy-d-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.Radiology 1995; 195: 339\u2013344.","journal-title":"Radiology"},{"key":"BF02988521_CR79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00259-001-0697-x","volume":"29","author":"EU Nitzche","year":"2002","unstructured":"Nitzche EU, Hoegerle S, Mix M, Brink I, Otte A, Moser E, et al. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?Eur J Nucl Med Mol Imaging 2002; 29: 237\u2013242.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF02988521_CR80","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/BF02285209","volume":"40","author":"K Yoshida","year":"1995","unstructured":"Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caised by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis.Dig Dis Sci 1995; 40: 1561\u20131568.","journal-title":"Dig Dis Sci"},{"key":"BF02988521_CR81","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1572-0241.1998.00260.x","volume":"93","author":"A Horiuchi","year":"1998","unstructured":"Horiuchi A, Kawa S, Akamatsu T, Aoki Y, Mukawa K, Furuya N, et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: A case report and review of the Japanese literature.Am J Gastroenterol 1998; 93: 260\u2013263.","journal-title":"Am J Gastroenterol"},{"key":"BF02988521_CR82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1572-0241.1998.099_c.x","volume":"93","author":"M Ohana","year":"1998","unstructured":"Ohana M, Okazaki K, Hajiro K, Kobashi Y. Multiple pancreatic masses associated with autoimmunity.Am J Gastroenterol 1998; 93: 99\u2013102.","journal-title":"Am J Gastroenterol"},{"key":"BF02988521_CR83","first-page":"2607","volume":"91","author":"A Horiuchi","year":"1996","unstructured":"Horiuchi A, Kaneko T, Yamamura N, Nagata A, Nakamura T, Akamatsu T, et al. Autoimmune chronic pancreatitis stimulating pancreatic lymphoma.Am J Gastroenterol 1996; 91: 2607\u20132609.","journal-title":"Am J Gastroenterol"},{"key":"BF02988521_CR84","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2214\/ajr.170.5.9574610","volume":"170","author":"H Irie","year":"1998","unstructured":"Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, et al. Autoimmune pancreatitis: CT and MR characteristics.AJR Am J Roentgenol 1998; 170: 1323\u20131327.","journal-title":"AJR Am J Roentgenol"},{"key":"BF02988521_CR85","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00004728-199811000-00007","volume":"22","author":"N Furukawa","year":"1998","unstructured":"Furukawa N, Muranaka T, Yasumori K, Matsubayashi R, Hayashida K, Arita Y. Autoimmune pancreatitis: Radiologic findings in three histologically proven case.J Comput Assist Tomogr 1998; 22: 880\u2013883.","journal-title":"J Comput Assist Tomogr"},{"key":"BF02988521_CR86","first-page":"1352","volume":"25","author":"M Zimny","year":"1998","unstructured":"Zimny M, Buell U, Diederichs CG, Reske SN. Falsepositive FDG PET in patients with pancreatic masses: an issue of proper patient selection?.Eur J Nucl Med 1998; 25: 1352.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR87","first-page":"133","volume":"221","author":"AL Warshaw","year":"1992","unstructured":"Warshaw AL, Fernandez-Del Castillo C. Pancraatic carcinoma.New Engl J Med 1992; 221: 133\u2013148.","journal-title":"New Engl J Med"},{"key":"BF02988521_CR88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-7404(97)00025-X","volume":"6","author":"A Riker","year":"1997","unstructured":"Riker A, Libutti SK, Bartlett DL. Advances in the early detection, diagnosis, and staging of pancreatic cancer.Surg Oncol 1997; 6: 157\u2013169.","journal-title":"Surg Oncol"},{"key":"BF02988521_CR89","first-page":"2437","volume":"19","author":"C Franke","year":"1999","unstructured":"Franke C, Klapdor R, Meyerhoff K, Schauman M. 18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma.Anticancer Res 1999; 19: 2437\u20132442.","journal-title":"Anticancer Res"},{"key":"BF02988521_CR90","first-page":"250","volume":"40","author":"A Frohlich","year":"1999","unstructured":"Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Detection of liver metastases from pancreatic cancer using FDG PET.J Nucl Med 1999; 40: 250\u2013255.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR91","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1095-0397(00)00068-6","volume":"3","author":"H Jadvar","year":"2000","unstructured":"Jadvar H, Fischman A. 2. Diagnostic Utility of FDG-PET in the Clinical Management of Patients with Suspected Recurrent Pancreatic Carcinoma after Whipple Procedure.Clin Positron Imaging 2000; 3: 156.","journal-title":"Clin Positron Imaging"},{"key":"BF02988521_CR92","first-page":"23","volume":"18","author":"G Benassai","year":"1999","unstructured":"Benassai G, Mastrorilli M, Mosella F, Mosella G. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.J Exp Clin Cancer Res 1999; 18: 23\u201328.","journal-title":"J Exp Clin Cancer Res"},{"key":"BF02988521_CR93","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.0.CO;2-8","volume":"67","author":"DC Allison","year":"1998","unstructured":"Allison DC, Piantadosi S, Hruban RH, Dooley WC, Fishman EK, Yeo CJ, et al. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma.J Surg Oncol 1998; 67: 151\u2013159.","journal-title":"J Surg Oncol"},{"key":"BF02988521_CR94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s004230050004","volume":"385","author":"C Gebhardt","year":"2000","unstructured":"Gebhardt C, Meyer W, Reichel M, Wunsch PH. Prognostic factor in the operative treatment of ductal pancreatic carcinoma.Langenbecks Arch Surg 2000; 385: 14\u201320.","journal-title":"Langenbecks Arch Surg"},{"key":"BF02988521_CR95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000658-199501000-00007","volume":"221","author":"SS Nitecki","year":"1995","unstructured":"Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Longterm survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving.Ann Surg 1995; 221: 59\u201366.","journal-title":"Ann Surg"},{"key":"BF02988521_CR96","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/030089169307900508","volume":"79","author":"C Speti","year":"1993","unstructured":"Speti C, Bonadimani B, Pasquali C, Piccoli A, Cappellazzo F, Rugge M, et al. Ductal adenocarcinoma of the pancreas: clinicopathologic features and survival.Tumori 1993; 79: 325\u2013330.","journal-title":"Tumori"},{"key":"BF02988521_CR97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s001170050093","volume":"36","author":"R Bares","year":"1996","unstructured":"Bares R, Dohmen B, Cremerius U, Fass J, Teusch M, Buell U, et al. Results of positron emission tomography with fluorine-18-labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma.Radiologe 1996; 36: 435\u2013440.","journal-title":"Radiologe"},{"key":"BF02988521_CR98","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000658-199602000-00006","volume":"223","author":"JG Fortner","year":"1996","unstructured":"Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.Ann Surg 1996; 223: 147\u2013153.","journal-title":"Ann Surg"},{"key":"BF02988521_CR99","volume-title":"TNM classification of malignant tumors","author":"P Hermanek","year":"1987","unstructured":"Hermanek P, Sobin LH.TNM classification of malignant tumors. 4th revised edition. New York, NY: Springer-Verlag, 1987.","edition":"4th revised edi"},{"key":"BF02988521_CR100","volume-title":"Classification on pancreatic carcinoma","author":"Japan Pancreas Society","year":"1996","unstructured":"Japan Pancreas Society.Classification on pancreatic carcinoma. (The 4th edition\/First English edition) June 1996. Kanehara & Co., LTD., Tokyo, Japan","edition":"The 4th edition"},{"key":"BF02988521_CR101","first-page":"494","volume":"18","author":"KE Bakkevold","year":"1992","unstructured":"Bakkevold KE, Arnesjo B, Kambestad B. Carcinoma of the pancreas and papilla of Vater\u2014assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients.Eur J Surg Oncol 1992; 18: 494\u2013507.","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"BF02988521_CR102","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s002590000287","volume":"27","author":"R Hustinx","year":"2000","unstructured":"Hustinx R, Dolin RJ, Benard F, Bhatnagar A, Chakraborty D, Smith RJ, et al. Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis.Eur J Nucl Med 2000; 27: (9): 1365\u20131371.","journal-title":"Eur J Nucl Med"},{"key":"BF02988521_CR103","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1054\/bjoc.2000.1496","volume":"83","author":"S Yasuda","year":"2000","unstructured":"Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahashi W, et al. Application of positron emission tomography imaging to cancer screening.Br J Cancer 2000; 83: 1607\u20131611.","journal-title":"Br J Cancer"},{"key":"BF02988521_CR104","first-page":"2026","volume":"41","author":"T Higashi","year":"2000","unstructured":"Higashi T, Fisher SJ, Brown RS, Nakada K, Walter GL, Wahl RL. Evaluation of the Early Effect of Local Irradiation on Normal Rodent Bone Marrow Metabolism using Fluorine-18-FDG; Preclinical Studies for PET.J Nucl Med 2000; 41: 2026\u20132035.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1054\/bjoc.2000.1166","volume":"83","author":"NR Maisey","year":"2000","unstructured":"Maisey NR, Webb A, Flux GD, Padhani A, Cunningham DC, Ott RJ, et al. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study.Br J Cancer 2000; 83: 287\u2013293.","journal-title":"Br J Cancer"},{"key":"BF02988521_CR106","first-page":"39","volume":"43","author":"K Higashi","year":"2002","unstructured":"Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, et al.18F-FDG uptake as a biologic prognostic factor for recurrence in patiens with surgically resected non-small cell lung cancer.J Nucl Med 2002; 43: 39\u201345.","journal-title":"J Nucl Med"},{"key":"BF02988521_CR107","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006231-200209000-00010","volume":"23","author":"HJ Jeong","year":"2002","unstructured":"Jeong HJ, Min JJ, Park JM, Chung JK, Kim BT, Jeong JM, et al. Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer.Nucl Med Commun 2002; 23: 865\u2013870.","journal-title":"Nucl Med Commun"},{"key":"BF02988521_CR108","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sj.bjc.6600114","volume":"86","author":"W Halfpenny","year":"2002","unstructured":"Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET. A possible prognostic factor in head and neck cancer.Br J Cancer 2002; 86: 512\u2013516.","journal-title":"Br J Cancer"},{"key":"BF02988521_CR109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02990079","volume":"16","author":"S Oku","year":"2002","unstructured":"Oku S, Nakagawa K, Momose T, Kumakura Y, Abe A, Watanabe T, et al. FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer.Ann Nucl Med 2002; 16: 409\u2013416.","journal-title":"Ann Nucl Med"},{"key":"BF02988521_CR110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hed.10037","volume":"24","author":"E Brun","year":"2002","unstructured":"Brun E, Kjellen E, Tenvall J, Ohlsson T, Sandell A, Perfekt R, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.Head Neck 2002; 24: 127\u2013135.","journal-title":"Head Neck"},{"key":"BF02988521_CR111","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0002-9610(02)00932-7","volume":"184","author":"H Kato","year":"2002","unstructured":"Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Masuda N, et al. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.Am J Surg 2002; 184: 279\u2013283.","journal-title":"Am J Surg"},{"key":"BF02988521_CR112","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2141.2001.03147.x","volume":"115","author":"R Naumann","year":"2001","unstructured":"Naumann R, Vaic A, Beuthien-Baumann B, Bredow J, Kropp J, Kittner T, et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma.Br J Haematol 2001; 115: 793\u2013800.","journal-title":"Br J Haematol"},{"key":"BF02988521_CR113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.119.2.333","volume":"119","author":"D Dunagan","year":"2001","unstructured":"Dunagan D, Chin R Jr, McCain T, Case L, Harkness B, Oaks T, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer.Chest 2001; 119: 333\u2013339.","journal-title":"Chest"},{"key":"BF02988521_CR114","first-page":"53","volume":"19","author":"B Nakata","year":"2001","unstructured":"Nakata B, Nishimura S, Ishikawa T, Ohira M, Nishino H, Kawabe J, et al. Prognostic predictive value of18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer.Int J Oncol 2001; 19: 53\u201358.","journal-title":"Int J Oncol"},{"key":"BF02988521_CR115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<695::AID-CNCR6>3.0.CO;2-D","volume":"79","author":"B Nakata","year":"1997","unstructured":"Nakata B, Chung YS, Nishimura S, Nishihara T, Sakurai Y, Sawada T, et al.18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.Cancer 1997; 79: 695\u2013699.","journal-title":"Cancer"},{"key":"BF02988521_CR116","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/003655200750023273","volume":"35","author":"M Zimny","year":"2000","unstructured":"Zimny M, Fass J, Bares R, Cremerius U, Sabri O, Buechin P, et al. Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma.Scand J Gastroenterol 2000; 35: 883\u2013888.","journal-title":"Scand J Gastroenterol"},{"key":"BF02988521_CR117","first-page":"263","volume":"49","author":"H Sugiura","year":"2002","unstructured":"Sugiura H, Kondo S, Islam HK, Ito K, Ono K, Morikawa T, et al. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas.Hepatogastroenterology 2002; 49: 263\u2013267.","journal-title":"Hepatogastroenterology"},{"key":"BF02988521_CR118","first-page":"962","volume":"48","author":"K Yamao","year":"2001","unstructured":"Yamao K, Ohashi K, Nakamura T, Suzuki T, Watanabe Y, Shimizu Y, et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary-mucinous tumor (IPMT) of the pancreas.Hepatogastroenterology 2001: 48: 962\u2013966.","journal-title":"Hepatogastroenterology"},{"key":"BF02988521_CR119","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000658-200111000-00014","volume":"234","author":"C Sperti","year":"2001","unstructured":"Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.Ann Surg 2001; 234: 675\u2013680.","journal-title":"Ann Surg"},{"key":"BF02988521_CR120","unstructured":"Higashi T, Saga T, Ishimori T, Mamede MH, Maetani Y, Ito K, et al. Diagnostic Value of18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Cystic Pancreatic Tumors, including Intraducal Papillary Mucinous Tumor (IPMT).J Nucl Med 2002; 43: 298P. (Proceedings of the SNM 49th Annual Meeting)"},{"key":"BF02988521_CR121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00006676-200003000-00001","volume":"20","author":"CG Diederichs","year":"2000","unstructured":"Diederichs CG, Staib L, Vogel J, Glasbrenner B, Glatting G, Brambs HJ, et al. Values and limitations of18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.Pancreas 2000; 20: 109\u2013116.","journal-title":"Pancreas"},{"key":"BF02988521_CR122","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00003072-200203000-00010","volume":"27","author":"M Papos","year":"2002","unstructured":"Papos M, Takacs T, Tron L, Farkas G, Ambrus E, Szakall S Jr, et al. The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions.Clin Nucl Med 2002; 27: 197\u2013201.","journal-title":"Clin Nucl Med"},{"key":"BF02988521_CR123","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002610000159","volume":"26","author":"H Jadvar","year":"2001","unstructured":"Jadvar H, Fischman AJ. Evaluation of pancreatic carcinoma with FDG PET.Abdom Imaging 2001; 26: 254\u2013259.","journal-title":"Abdom Imaging"},{"key":"BF02988521_CR124","unstructured":"Shields AF, Ahmed S, Zalupski MM, et al. FDG PET evaluation of pancreatic cancer treatment [abstract].J Nucl Med 1999; 40: 243P. (Proceedings of the SNM 46th Annual Meeting)"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02988521\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T19:56:10Z","timestamp":1558554970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02988521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["BF02988521"],"URL":"https:\/\/doi.org\/10.1007\/bf02988521","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}